Published in Periodontol 2000 on January 01, 2007
Oral inflammatory diseases and systemic inflammation: role of the macrophage. Front Immunol (2012) 1.07
A histological evaluation of a low-level laser therapy as an adjunct to periodontal therapy in patients with diabetes mellitus. Lasers Med Sci (2012) 0.87
Association between oral health status and type 2 diabetes mellitus among Sudanese adults: a matched case-control study. PLoS One (2013) 0.87
Oxidative stress in diabetes and periodontitis. N Am J Med Sci (2013) 0.82
Non-surgical periodontal therapy with and without subgingival minocycline administration in patients with poorly controlled type II diabetes: a randomized controlled clinical trial. Clin Oral Investig (2011) 0.81
Effect of glycemic control on periodontitis in type 2 diabetic patients with periodontal disease. J Diabetes Investig (2013) 0.80
The influence of diabetes mellitus on periodontal tissues: a pilot study. J Periodontal Implant Sci (2010) 0.80
Assessment of Alloxan-Induced Diabetic Rats as a Periodontal Disease Model Using a Selective Cyclooxygenase (COX)-2 Inhibitor. J Toxicol Pathol (2014) 0.77
Effect of locally delivered tetracycline hydrochloride as an adjunct to scaling and root planing on Hba1c, C-reactive protein, and lipid profile in type 2 diabetes: A clinico-biochemical study. Contemp Clin Dent (2012) 0.77
Management of diabolical diabetes mellitus and periodontitis nexus: Are we doing enough? World J Diabetes (2016) 0.75
Effect of β-anhydroicaritin on the expression levels of tumor necrosis factor-α and matrix metalloproteinase-3 in periodontal tissue of diabetic rats. Mol Med Rep (2015) 0.75
Preventive dental care in older adults with diabetes. J Am Dent Assoc (2016) 0.75
The relationship between periapical lesions and the serum levels of glycosylated hemoglobin and C-reactive protein in type 2 diabetic patients. Saudi Med J (2017) 0.75
Diabetes as a risk factor for medication-related osteonecrosis of the jaw. J Dent Res (2014) 0.75
Systemic lycopene as an adjunct to scaling and root planing in chronic periodontitis patients with type 2 diabetes mellitus. J Int Soc Prev Community Dent (2015) 0.75
The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med (1993) 102.56
Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ (2000) 35.06
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (1998) 34.34
Biochemistry and molecular cell biology of diabetic complications. Nature (2001) 25.43
Acute-phase proteins and other systemic responses to inflammation. N Engl J Med (1999) 18.25
Toll-like receptors and innate immunity. Nat Rev Immunol (2001) 16.50
Atherosclerosis. Nature (2000) 15.95
C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA (2001) 15.85
Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature (2000) 12.33
Points of control in inflammation. Nature (2002) 10.61
Role of oxidative stress in development of complications in diabetes. Diabetes (1991) 8.27
NADPH oxidase: an update. Blood (1999) 7.65
Decoding the patterns of self and nonself by the innate immune system. Science (2002) 7.19
Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. Endocr Rev (2002) 6.05
Oxidative stress and diabetic vascular complications. Diabetes Care (1996) 5.97
The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses. J Clin Invest (2001) 5.49
Is type II diabetes mellitus a disease of the innate immune system? Diabetologia (1998) 5.43
NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X. Diabetologia (1997) 4.88
The bacterial etiology of destructive periodontal disease: current concepts. J Periodontol (1992) 4.76
High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C--dependent activation of NAD(P)H oxidase in cultured vascular cells. Diabetes (2000) 4.55
Molecular understanding of hyperglycemia's adverse effects for diabetic complications. JAMA (2002) 4.18
Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): a cohort study. Lancet (1999) 4.07
Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins. J Biol Chem (1994) 3.73
Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation. Proc Natl Acad Sci U S A (2000) 3.36
The NAD(P)H oxidase homolog Nox4 modulates insulin-stimulated generation of H2O2 and plays an integral role in insulin signal transduction. Mol Cell Biol (2004) 3.35
Periodontal disease and diabetes mellitus: a two-way relationship. Ann Periodontol (1998) 3.12
Protein kinase C activation and the development of diabetic complications. Diabetes (1998) 2.93
Defective inflammatory response in interleukin 6-deficient mice. J Exp Med (1994) 2.92
Cachectin/TNF and IL-1 induced by glucose-modified proteins: role in normal tissue remodeling. Science (1988) 2.87
Amelioration of vascular dysfunctions in diabetic rats by an oral PKC beta inhibitor. Science (1996) 2.80
Design of lipoxin A4 stable analogs that block transmigration and adhesion of human neutrophils. Biochemistry (1995) 2.75
Periodontal diseases: pathogenesis. Ann Periodontol (1996) 2.71
Dynamic O-linked glycosylation of nuclear and cytoskeletal proteins. Annu Rev Biochem (1997) 2.69
Bisphosphonate action. Alendronate localization in rat bone and effects on osteoclast ultrastructure. J Clin Invest (1991) 2.63
Insulin-stimulated hydrogen peroxide reversibly inhibits protein-tyrosine phosphatase 1b in vivo and enhances the early insulin action cascade. J Biol Chem (2001) 2.60
Activation of the receptor for advanced glycation end products triggers a p21(ras)-dependent mitogen-activated protein kinase pathway regulated by oxidant stress. J Biol Chem (1997) 2.53
Treatment of periodontal disease in diabetics reduces glycated hemoglobin. J Periodontol (1997) 2.39
Glycemic control of type 2 diabetes and severe periodontal disease in the US adult population. Community Dent Oral Epidemiol (2002) 2.34
Blockade of receptor for advanced glycation end-products restores effective wound healing in diabetic mice. Am J Pathol (2001) 2.33
Differences in cellular infiltrate and extracellular matrix of chronic diabetic and venous ulcers versus acute wounds. J Invest Dermatol (1998) 2.30
Reduced inflammation and tissue damage in transgenic rabbits overexpressing 15-lipoxygenase and endogenous anti-inflammatory lipid mediators. J Immunol (2003) 2.23
Circulating interleukin 6 levels, blood pressure, and insulin sensitivity in apparently healthy men and women. J Clin Endocrinol Metab (2001) 2.22
Regulation of endothelial constitutive nitric oxide synthase gene expression in endothelial cells and in vivo : a specific vascular action of insulin. Circulation (2000) 2.18
Vascular superoxide production by NAD(P)H oxidase: association with endothelial dysfunction and clinical risk factors. Circ Res (2000) 2.15
Aminoguanidine treatment inhibits the development of experimental diabetic retinopathy. Proc Natl Acad Sci U S A (1991) 2.12
Lipid mediator networks in cell signaling: update and impact of cytokines. FASEB J (1996) 2.09
Hydrogen peroxide generated during cellular insulin stimulation is integral to activation of the distal insulin signaling cascade in 3T3-L1 adipocytes. J Biol Chem (2001) 2.06
Protein kinase C activation: isozyme-specific effects on metabolism and cardiovascular complications in diabetes. Diabetologia (2001) 1.98
Lipoxin biosynthesis and its impact in inflammatory and vascular events. Biochim Biophys Acta (1994) 1.98
Amelioration of accelerated diabetic mesangial expansion by treatment with a PKC beta inhibitor in diabetic db/db mice, a rodent model for type 2 diabetes. FASEB J (2000) 1.93
Severe periodontitis and risk for poor glycemic control in patients with non-insulin-dependent diabetes mellitus. J Periodontol (1996) 1.90
Protein kinase C-dependent increase in reactive oxygen species (ROS) production in vascular tissues of diabetes: role of vascular NAD(P)H oxidase. J Am Soc Nephrol (2003) 1.89
Plasma interleukin-6, tumour necrosis factor alpha and blood cytokine production in type 2 diabetes. Life Sci (2000) 1.85
Blockade of RAGE suppresses periodontitis-associated bone loss in diabetic mice. J Clin Invest (2000) 1.82
Endothelial function in health and disease: new insights into the genesis of cardiovascular disease. Am J Med (1998) 1.76
Expression of phagocyte NADPH oxidase components in human endothelial cells. Am J Physiol (1996) 1.75
The use of crevicular fluid prostaglandin E2 levels as a predictor of periodontal attachment loss. J Periodontal Res (1986) 1.72
Maillard reaction products in tissue proteins: new products and new perspectives. Amino Acids (2003) 1.62
Oxidative stress and glycemic regulation. Metabolism (2000) 1.62
Effect of aldose reductase inhibition on nerve conduction and morphometry in diabetic neuropathy. Zenarestat Study Group. Neurology (1999) 1.60
Human and rat mesangial cell receptors for glucose-modified proteins: potential role in kidney tissue remodelling and diabetic nephropathy. J Exp Med (1991) 1.59
Type 2 diabetes mellitus and periodontal disease. J Am Dent Assoc (1990) 1.59
Receptor-specific increase in extracellular matrix production in mouse mesangial cells by advanced glycosylation end products is mediated via platelet-derived growth factor. Proc Natl Acad Sci U S A (1992) 1.58
Retardation by aminoguanidine of development of albuminuria, mesangial expansion, and tissue fluorescence in streptozocin-induced diabetic rat. Diabetes (1991) 1.58
Aspirin-triggered lipoxins (15-epi-LX) are generated by the human lung adenocarcinoma cell line (A549)-neutrophil interactions and are potent inhibitors of cell proliferation. Mol Med (1996) 1.55
Polyol pathway and diabetic peripheral neuropathy. Int Rev Neurobiol (2002) 1.53
Cytokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy. Curr Eye Res (1995) 1.49
Unorthodox routes to prostanoid formation: new twists in cyclooxygenase-initiated pathways. J Clin Invest (2001) 1.49
Molecular mechanisms of tumor necrosis factor alpha gene expression in monocytic cells via hyperglycemia-induced oxidant stress-dependent and -independent pathways. J Biol Chem (2000) 1.49
Hyperglycemia, polyol metabolism, and complications of diabetes mellitus. Annu Rev Med (1975) 1.41
Molecular identity and cellular distribution of advanced glycation endproduct receptors: relationship of p60 to OST-48 and p90 to 80K-H membrane proteins. Proc Natl Acad Sci U S A (1996) 1.40
Glycation induces expansion of the molecular packing of collagen. J Mol Biol (1988) 1.39
Periodontal disease and NIDDM in Pima Indians. Diabetes Care (1990) 1.36
Doxycycline inhibits neutrophil (PMN)-type matrix metalloproteinases in human adult periodontitis gingiva. J Clin Periodontol (1995) 1.35
Translocation of glomerular p47phox and p67phox by protein kinase C-beta activation is required for oxidative stress in diabetic nephropathy. Diabetes (2003) 1.35
Tumor necrosis factor modulates fibroblast apoptosis, PMN recruitment, and osteoclast formation in response to P. gingivalis infection. J Dent Res (2001) 1.34
A role for advanced glycation end products in diminished bone healing in type 1 diabetes. Diabetes (2003) 1.34
Enhanced superoxide release and elevated protein kinase C activity in neutrophils from diabetic patients: association with periodontitis. J Leukoc Biol (2005) 1.31
Altered cytokine and nitric oxide secretion in vitro by macrophages from diabetic type II-like db/db mice. Diabetes (2000) 1.30
Increased levels of soluble vascular cell adhesion molecule 1 are associated with risk of cardiovascular mortality in type 2 diabetes: the Hoorn study. Diabetes (2000) 1.27
Increased NAD(P)H oxidase-mediated superoxide production in renovascular hypertension: evidence for an involvement of protein kinase C. Kidney Int (1999) 1.25
p40(phox) is phosphorylated on threonine 154 and serine 315 during activation of the phagocyte NADPH oxidase. Implication of a protein kinase c-type kinase in the phosphorylation process. J Biol Chem (1998) 1.24
Receptor-specific induction of insulin-like growth factor I in human monocytes by advanced glycosylation end product-modified proteins. J Clin Invest (1992) 1.23
Acute hyperglycemia induces an oxidative stress in healthy subjects. J Clin Invest (2001) 1.23
Glucose-induced protein kinase C activation regulates vascular permeability factor mRNA expression and peptide production by human vascular smooth muscle cells in vitro. Diabetes (1997) 1.22
Non-insulin dependent diabetes mellitus and alveolar bone loss progression over 2 years. J Periodontol (1998) 1.20
Adverse effects of dietary glycotoxins on wound healing in genetically diabetic mice. Diabetes (2003) 1.14
The role of the host response in periodontal disease progression: implications for future treatment strategies. J Periodontol (1993) 1.13
High glucose concentrations increase endothelial cell permeability via activation of protein kinase C alpha. Circ Res (1997) 1.10
Cytokine secretion is impaired in women with diabetes mellitus. Eur J Clin Invest (2000) 1.09
Insulin-induced activation of NADPH-dependent H2O2 generation in human adipocyte plasma membranes is mediated by Galphai2. J Biol Chem (1997) 1.07
Progression of nephropathy in spontaneous diabetic rats is prevented by OPB-9195, a novel inhibitor of advanced glycation. Diabetes (1997) 1.05
Early and intermediate Amadori glycosylation adducts, oxidative stress, and endothelial dysfunction in the streptozotocin-induced diabetic rats vasculature. Diabetologia (2003) 1.04
Laminin alterations after in vitro nonenzymatic glycosylation. Diabetes (1990) 1.04
Periodontal status of diabetic and non-diabetic men: effects of smoking, glycemic control, and socioeconomic factors. J Periodontol (1996) 1.00
Nerve conduction and aldose reductase inhibition during 5 years of diabetes or galactosaemia in dogs. Diabetologia (1994) 0.98
Oxidative stress: the lead or supporting actor in the pathogenesis of diabetic complications. J Am Soc Nephrol (2003) 0.96
Resolvin E1 regulates inflammation at the cellular and tissue level and restores tissue homeostasis in vivo. J Immunol (2007) 2.66
Apoptotic neutrophils and T cells sequester chemokines during immune response resolution through modulation of CCR5 expression. Nat Immunol (2006) 2.37
Reduced inflammation and tissue damage in transgenic rabbits overexpressing 15-lipoxygenase and endogenous anti-inflammatory lipid mediators. J Immunol (2003) 2.23
Platelet-rich plasma: growth factors and pro- and anti-inflammatory properties. J Periodontol (2007) 1.98
Hereditary gingival fibromatosis associated with generalized aggressive periodontitis: a case report. J Periodontol (2004) 1.36
Inflammatory and immune pathways in the pathogenesis of periodontal disease. Periodontol 2000 (2014) 1.20
Priming of neutrophil oxidative burst in diabetes requires preassembly of the NADPH oxidase. J Leukoc Biol (2008) 1.19
TLR cross-talk specifically regulates cytokine production by B cells from chronic inflammatory disease patients. J Immunol (2009) 1.16
A molecular defect in intracellular lipid signaling in human neutrophils in localized aggressive periodontal tissue damage. J Immunol (2004) 1.12
Diabetes-induced oxidative stress is mediated by Ca2+-independent phospholipase A2 in neutrophils. J Immunol (2010) 1.11
Adjunctive treatment of chronic periodontitis with daily dietary supplementation with omega-3 Fatty acids and low-dose aspirin. J Periodontol (2010) 1.10
Activation of RAGE induces elevated O2- generation by mononuclear phagocytes in diabetes. J Leukoc Biol (2006) 1.10
Modeling of trabecular bone and lamina dura following selective alveolar decortication in rats. J Periodontol (2008) 1.09
Oral inflammatory diseases and systemic inflammation: role of the macrophage. Front Immunol (2012) 1.07
Hyperactivated B cells in human inflammatory bowel disease. J Leukoc Biol (2009) 1.03
Chronic hyperglycemia predisposes to exaggerated inflammatory response and leukocyte dysfunction in Akita mice. J Immunol (2006) 1.02
Mice lacking inducible nitric oxide synthase demonstrate impaired killing of Porphyromonas gingivalis. Infect Immun (2003) 1.01
Efficacy of amoxicillin and metronidazole combination for the management of generalized aggressive periodontitis. J Periodontol (2010) 0.99
Mechanism of action and morphologic changes in the alveolar bone in response to selective alveolar decortication-facilitated tooth movement. Am J Orthod Dentofacial Orthop (2011) 0.98
Epithelial to mesenchymal transition in gingival overgrowth. Am J Pathol (2010) 0.98
Phosphorylation of pleckstrin increases proinflammatory cytokine secretion by mononuclear phagocytes in diabetes mellitus. J Immunol (2007) 0.98
B cells from periodontal disease patients express surface Toll-like receptor 4. J Leukoc Biol (2008) 0.96
Paradigm shift in the pharmacological management of periodontal diseases. Front Oral Biol (2011) 0.94
Photobiomodulation accelerates orthodontic alignment in the early phase of treatment. Prog Orthod (2013) 0.93
Porphyromonas gingivalis lipid A phosphatase activity is critical for colonization and increasing the commensal load in the rabbit ligature model. Infect Immun (2013) 0.92
Clinical and biochemical effects of diode laser as an adjunct to nonsurgical treatment of chronic periodontitis: a randomized, controlled clinical trial. Lasers Med Sci (2012) 0.92
Immune response of macrophages from young and aged mice to the oral pathogenic bacterium Porphyromonas gingivalis. Immun Ageing (2010) 0.90
Localized aggressive periodontitis is linked to human chromosome 1q25. Hum Genet (2003) 0.89
Performance of multiplex cytokine assays in serum and saliva among community-dwelling postmenopausal women. PLoS One (2013) 0.88
Toll-like receptor 2 induces mucosal homing receptor expression and IgA production by human B cells. Clin Immunol (2010) 0.87
Multicentric reticulohistiocytosis: a systemic osteoclastic disease? Arthritis Rheum (2008) 0.87
Gingival inflammation and interleukin-1 beta and tumor necrosis factor-alpha levels in gingival crevicular fluid during the menstrual cycle. J Periodontol (2009) 0.86
Resolvin D1 protects periodontal ligament. Am J Physiol Cell Physiol (2013) 0.86
A critical role for suppressors of cytokine signaling 3 in regulating LPS-induced transcriptional activation of matrix metalloproteinase-13 in osteoblasts. PeerJ (2013) 0.82
The use of light/chemically hardened polymethylmethacrylate, polyhydroxyethylmethacrylate, and calcium hydroxide graft material in combination with polyanhydride around implants in minipigs: part I: immediate stability and function. J Periodontol (2011) 0.81
Role for moesin in lipopolysaccharide-stimulated signal transduction. Infect Immun (2004) 0.81
Ceruloplasmin induces polymorphonuclear leukocyte priming in localized aggressive periodontitis. J Periodontol (2009) 0.81
Arginine deiminase inhibits Porphyromonas gingivalis surface attachment. Microbiology (2012) 0.79
Blocking proinflammatory cytokine release modulates peripheral blood mononuclear cell response to Porphyromonas gingivalis. J Periodontol (2012) 0.79
Activation and resolution of periodontal inflammation and its systemic impact. Periodontol 2000 (2015) 0.79
Full-mouth rehabilitation of a patient with ectodermal dysplasia with dental implants. J Oral Implantol (2014) 0.79
1-Tetradecanol complex reduces progression of Porphyromonas gingivalis-induced experimental periodontitis in rabbits. J Periodontol (2007) 0.79
Combined use of platelet-rich plasma and bone grafting with or without guided tissue regeneration in the treatment of anterior interproximal defects. J Periodontol (2007) 0.78
Effect of neutrophil apoptosis on monocytic cytokine response to Porphyromonas gingivalis lipopolysaccharide. J Periodontol (2005) 0.78
CD38 expression in neutrophils from patients with localized aggressive periodontitis. J Periodontol (2005) 0.78
Matrix metalloproteinases and chemokines in the gingival crevicular fluid during orthodontic tooth movement. Eur J Orthod (2011) 0.78
A prospective, randomized clinical study evaluating the effect of transdermal continuous oxygen therapy on biological processes and foot ulcer healing in persons with diabetes mellitus. Ostomy Wound Manage (2013) 0.77
Simultaneous measurements of cytoplasmic Ca2+ responses and intracellular pH in neutrophils of localized aggressive periodontitis (LAP) patients. J Leukoc Biol (2005) 0.77
IgG antibody levels to Porphyromonas gingivalis and clinical measures in children. J Periodontol (2004) 0.77
A pilot study evaluating non-contact low-frequency ultrasound and underlying molecular mechanism on diabetic foot ulcers. Int Wound J (2012) 0.76
Animal models for periodontal regeneration and peri-implant responses. Periodontol 2000 (2015) 0.76
IPLA2 mRNA expression by human neutrophils in type 2 diabetes and chronic periodontitis. J Int Acad Periodontol (2014) 0.76
1-Tetradecanol complex: therapeutic actions in experimental periodontitis. J Periodontol (2009) 0.75
Tissue repair after selective alveolar corticotomy in orthodontic patients:A preliminary study. Angle Orthod (2017) 0.75
Dramatic oral findings belonging to a pica patient: a case report. Int Dent J (2009) 0.75
Conclusion and Future Directions. Front Oral Biol (2015) 0.75
Surgical Methods for the Acceleration of the Orthodontic Tooth Movement. Front Oral Biol (2015) 0.75
Preface. Front Oral Biol (2016) 0.75
Implant-supported full-mouth restoration in a young patient with generalized aggressive periodontitis. J Oral Implantol (2013) 0.75
Nonsurgical Methods for the Acceleration of the Orthodontic Tooth Movement. Front Oral Biol (2015) 0.75
Molecular basis for immunohistochemical and inflammatory changes during progression of gingivitis to periodontitis. Periodontol 2000 (2017) 0.75
Identification of mRNAs for the various diacylglycerol kinase isoforms in neutrophils from patients with localized aggressive periodontitis. J Periodontal Res (2003) 0.75